Cognitive-Motor Rehabilitation, Stimulant Drugs, and Active Control in the Treatment of ADHD
NCT ID: NCT02780102
Last Updated: 2021-02-03
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
48 participants
INTERVENTIONAL
2015-09-30
2017-08-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Computer-assisted Cognitive Rehabilitation (CACR), Placebo CACR and Psycho-stimulants in the Treatment of ADHD
NCT01675804
Neurofeedback-Based Digital Therapeutics for the Diagnosis and Treatment of ADHD in Children.
NCT06369714
Impact of Stimulants and In-Scanner Motion on Attentive Task Performance in ADHD (ADHD_NFB)
NCT06779825
The Effect of Methylphenidate Treatment in Familial Attention Deficit/Hyperactivity Disorder (ADHD)
NCT01554046
Concerta and Strattera on the Executive Function in Attention Deficit Hyperactivity Disorder (ADHD) Children
NCT01065259
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
SINGLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Cognitive-Motor Rehabilitation
Cognitive-Motor Rehabilitation (CMR): 20 sixty-minute sessions of cognitive-motor rehabilitation
Cognitive-Motor Rehabilitation
Cognitive-Motor Rehabilitation (CMR) group received 20 sixty-minute sessions of cognitive-motor exercises
Ritalin
2 to 3 doses of 10 mg Ritalin tablets per day during 8 week.
Ritalin
2 or 3 doses of 10 mg tablets of immediate-release Methylphenidate (Ritalin) per day for 8 week.
Active Control
Active Control group simultaneously received 20 sixty-minute sessions of low dose cognitive-motor exercises
Active Control
Active Control group simultaneously received 20 sixty-minute sessions of low dose cognitive-motor exercises
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Cognitive-Motor Rehabilitation
Cognitive-Motor Rehabilitation (CMR) group received 20 sixty-minute sessions of cognitive-motor exercises
Ritalin
2 or 3 doses of 10 mg tablets of immediate-release Methylphenidate (Ritalin) per day for 8 week.
Active Control
Active Control group simultaneously received 20 sixty-minute sessions of low dose cognitive-motor exercises
Other Intervention Names
Discover alternative or legacy names that may be used to describe the listed interventions across different sources.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* aged between 9 and 12 years
* Intelligence Quotient (IQ)\>90
Exclusion Criteria
* A history of seizures during past 2 years
* Disability or handicap preventing the child from participating cognitive-motor exercises
* Sever medical conditions requiring immediate medical treatment
9 Years
12 Years
MALE
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Allameh Tabatabai University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Saeed Azami
Mr.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Saeed Azami, PhD
Role: STUDY_DIRECTOR
Semnan University
Zeynab AliMadadi, MD
Role: PRINCIPAL_INVESTIGATOR
Tehran University of medical Science
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Counseling and guidence Center of the Department of education of region 9 of Tehran
Tehran, , Iran
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
328/94/16090
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.